1Choo QL,Kuo G,Weiner AJ,et al.Isolation of a cDNA clone derived from a blood-brone non-A,non-B viral hepatitis genome[J].Science,1989,244(4902):359-362. 被引量：1
2Strauss R,Trner A,Duberg AS,et al.Hepatocellular carcinoma and other primary liver cancers in hepatitis C patients in Sweden-a low endemic country[J].J Viral Hepat,2008,15(7):531-537. 被引量：1
3Penin F,Dubuisson J,Rey FA,et al.Structural biology of hepatitis C virus[J].Hepatology,2004,39(1):5-19. 被引量：1
4Luo G,Hamatake PK,Mathis DM,et al.De Novo initiation of RNA Synthesis by the RNA-Dependent RNA Polymerase(NS5B) of hepatitis C virus[J].J Virol,2000,74(2):851-863. 被引量：1
5Nobuyuki K.Molecular Virology of Hepatitis C Virus[J].Acta Med Okayama,2001,55(3):133-159. 被引量：1
6Peter S,Jens B,Christophe C,et al.Consensus Proposals for a Unified System ofNomenclature of Hepatitis C Virus Genotypes[J].HEPATOLOGY,2005,42(2):962-973. 被引量：1
8Volker B,Darius M,Hubert E.Molecular Virology of Hepatitis C Virus(HCV):2006 Update[J].Int J Med Sci,2006,3(2):29-34. 被引量：1
9Vander Poel CL,Cuypers HT,Reesink HW,et al.Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay[J].Lancet,1991,337(8737):317-319. 被引量：1
4Saldanha J, Lelie N, Heath A. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. Who collaborative study group.Vox Sang 1999;76:149-158. 被引量：1
5Lefrere JJ, Guirammand S, Lefrere F, Mariotti M, Aumont P,Lerable J, Petit JC, Girot R, Morand-Joubert L. Full or partial seroversion in patients infected by hepatitis C virus. J Infect Dis 1997;175:316-322. 被引量：1
6Alter MJ, Kuhnert WL, Finelli L. Centers for disease control and prevention. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Mmwr 2003;52:1-13. 被引量：1
7Chou R, Clark EC, Helfand M. US preventive services task force. Screening for hepatitis C virus infection: a review of the evidence for the U.S. preventive services task force. Ann Intern Med 2004;140:465-479. 被引量：1
8Lorenzo J, Castro A, Aguilera A, Prieto E, Lopez-Calvo S,Regueiro B, Pedreira J. Total HCV core antigen assay; A new marker of HCV viremia and its application during treatment of chronic hepatitis C. J Virol Methods 2004;120:173-177. 被引量：1
9Manns MP, Mchutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK.Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 2001;358:958-965. 被引量：1
10Hadziyannis SJ, Cheinquer H, Morgan T, Diago M, Jensen DM, Sette H, Ramadori G, Bodenheimer HC, Marcellin P, Lee SD, Roberts PJ, Ackrill AM. Peginterferon alfa-2a(40 KD)(pegasys) in combination with ribavirin (RBV): efficacy and safety results from a phase Ⅲ, randomized, double-blind,multicentre study examining effect of duration of treatment and RBV dose. J Hepatol 2002;36:S3. 被引量：1
3Terrault NA, Dodge JL, Murphy EL, et al. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study[J]. Hepatology, 2013, 57(3): 881-889. DOh 10.1002/hep.26164. 被引量：1
4Nakamura I, Tanaka Y, Oehiai K, et al. Clarification of interspnusal hepatitis C virus infection in acute hepatitis C patients by molecular evolutionary analyses: Consideration on sexual and non-sexual transmission between spouses[J]. Hepatol Res, 2011, 41(9): 838-845. DOh 10.1111/ j. 1872-034X.2011.00843.x. 被引量：1
5Esteban JI, G6mez J, Martell M, et al. Transmission of hepatitis C virus by a cardiac surgeon[J]. N Engl J Med, 1996, 334(9): 555-560. DOh 10.1056/NEJM 199602293340902. 被引量：1
6Ramachandran S, Xia GL, Ganova-Raeva LM, et ah End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: performance under optimal and suboptimal conditions[]]. ] Virol Methods, 2008, 151 (2): 217-224. DOI: 10.1016/j.j viromet.2008.05.005. 被引量：1
7Ison MG, Llata E, Conover CS, et al. Transmission of human inmmnodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients[J]. Am J Transplant, 2011, 11(6): 1218-1225. DOI: 10.1111/j.1600-6143.2011.03597.x. 被引量：1
8Pahner BA, Dimitrova Z, Skums P, et al. Analysis of the evolution and structure of a complex intrahost viral population in chronic hepatitis C virus mapped by uhradeep pyrosequencing[J]. J Virol, 2014, 88(23): 13709-13721. DOI: 10.1128/JVI.01732-14. 被引量：1
9Dietz J, Schelhorn SE, Fitting D, et al. Deep sequencing reveals mutagenic effects of ribavirin during monotherapy of hepatitis C virus genotype 1-infected patients[J]. J Virol, 2013, 87(11): 6172-6181. DOI: 10.1128/JVI.02778-12. 被引量：1
10Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region[J]. J Gen Virol, 1993, 74 ( Pt 11): 2391-2399. DOI: 10.1099/ 0022-1317-74-11-2391. 被引量：1
